Test Equipment

Develop and Test Software with CANoe4SW

Stuttgart/GERMANY, 2020-12-01 – Vector introduces CANoe4SW – a tool for the development, test, and analysis of software in cyber physical systems. CANoe4SW supports software developers and testers in all markets throughout the entire development process of distributed systems and IoT devices. In virtual execution environments on the PC, in virtual machines or in the cloud, the user achieves high-quality software at an early stage of development for any target operating system based on Windows or Linux.

CANoe4SW provides developers with a comprehensive tool for development, test, and analysis of software in cyber physical systems. It is not important whether the software to be tested is a single software component, a subsystem or the entire distributed system. Software developers and testers in all markets, e.g. medical, railway, automotive, use CANoe4SW along the entire development process of distributed systems and IoT devices. Virtual execution environments on the computer, in virtual machines, or in the cloud enable software to be tested for any target operating system based on Windows or Linux, e.g. Ubuntu, CentOS, SUSE.

CANoe4SW allows easy access to the System Under Test by its functional system interfaces at a pure software level. Testers can perform early “black-box” SIL testing independently of hardware availability. CANoe4SW integrates seamlessly in CI/CT environments. Furthermore, the support of connectivity protocols such as MQTT provides access to IoT devices and back end software running in the cloud.

Interactive development and test as well as simple automated testing helps to ensure quality of distributed systems. CANoe4SW supports testing at an early stage of the development process by using virtual execution environments, thereby significantly increasing the quality of the developed software. Complex systems become manageable by isolating individual components using models for the physical and software environments. Software developers use CANoe4SW to stimulate and monitor values over time, thereby also addressing dynamic aspects of the software under test. Advantage: Users simulate error scenarios that would be difficult to implement in real environments, e.g. downtimes of cloud services. In contrast to debugging on the target, the virtual execution environments provide the user with more options for error detection in his development environment. The independence of hardware and other software components also enables the use of CI/CT environments from the very beginning.

CANoe4SW is the right tool for monitoring fully integrated software components using models to simulate the physical environment and software environment. In addition to interactive development and testing, automated testing is a key feature of CANoe4SW.

More information at: www.vector.com/CANoe4SW

Liat

Recent Posts

Tower Semiconductor Secures $1.3 Billion Silicon Photonics Agreements and Reports Strong Q1 2026 Growth

Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…

3 days ago

14 Israeli Cybersecurity Companies Named to the Rising in Cyber 2026 List of the World’s Most Promising Cyber Startups

The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…

3 days ago

Sequent Selected by 15 Canadian Municipalities to Deliver Verifiable, Trust-Based Digital Voting for Elections

More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…

3 days ago

Sheba and Ichilov Medical Centers Join AccuLine’s International Clinical Trial for AI-Driven Early Heart Attack Risk Assessment

The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…

3 days ago

Molex Completes Acquisition of Teramount Ltd.

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…

6 days ago

Immunai Expands Oncology Collaboration, Extending AI-Driven Biomarker and Clinical Insights Through 2027

This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…

6 days ago